New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > VERTEX PHARMACEUTICALS INC / MA
VERTEX PHARMACEUTICALS INC / MA
Industry: Life Sciences ・ $VRTX on Nasdaq ・ Market Cap: Large
CEO Sales
Top Executive Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
TRADES PURCHASE/SALE Sector Average | 0 / 39 2.19 / 7.65 |
INSIDER BUYERS/SELLERS Sector Average | 0 / 12 1.2 / 2.5 |
SHARES PURCHASED/SOLD Transaction Average | 0 / 169,320 0 / 4,342 |
VALUE PURCHASED/SOLD Transaction Average | $0 / $75,794,662 $0 / $1,943,453 |
PURCHASE RANGE | N/A |
SALE RANGE | $131,955.36 - $7,677,010 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
0 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
2 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
No Insider Trades made
0%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
51.9%
DIRECTORS
48.1%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.463 0.295 |
VALUE GINI INDEX Sector Average | 0.464 0.288 |
VERTEX PHARMACEUTICALS INC / MA 1Y Trade Transactions